← Back to headlines
H.C. Wainwright Raises Price Target for ImmunityBio to $15
H.C. Wainwright has increased its price target for ImmunityBio, Inc. (IBRX) to $15 from $10, maintaining a Buy rating on the company's shares.
6 Mar, 15:20 — 6 Mar, 15:20
Sources
Showing 1 of 1 sources
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Four Arrested for Selling P102 Million in Counterfeit Anti-Cancer Medicine in Makati
just now
Oil Traffic Through Danish Straits Reaches Historic Highs, Raising Safety and Pollution Concerns
15m ago
Poland Increases Subsidies for Employees with Disabilities in 2026
28m ago